Scroll for more

Rules and Regulation

DC 7.2 Review of Atypical Findings from Tests initiated by FINA

DC 7.2.1 As provided in the International Standard for Laboratories, in some circumstances laboratories are directed to report the presence of Prohibited Substances, which may also be produced endogenously as Atypical Findings, i.e. as findings that are subject to further investigation.

DC 7.2.2 Upon receipt of an Atypical Finding, FINA shall conduct a review to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions, or (b) there is any apparent departure from the International Standard for Testing and Investigations or International Standard for Laboratories that caused the Atypical Finding.

DC 7.2.3 If the review of an Atypical Finding under DC 7.2.2 does not reveal an applicable TUE or a departure from the International Standard for Testing and Investigations or the International Standard for Laboratories that caused the Atypical Finding, FINA shall conduct the required investigation. After the investigation is completed, the Athlete, the Athlete’s Member Federation, the Athlete’s National Anti-Doping Organisation and WADA shall be notified whether or not the Atypical Finding will be brought forward as an Adverse Analytical Finding. The Athlete shall be notified as provided in DC 7.1.3.

DC 7.2.4 FINA will not provide notice of an Atypical Finding until it has completed its investigation and has decided whether it will bring the Atypical Finding forward as an Adverse Analytical Finding unless one of the following circumstances exists:

(a) If the DCRB or its designee determines the B Sample should be analyzed prior to the conclusion of its investigation, FINA may conduct the B Sample analysis after notifying the Athlete, with such notice to include a description of the Atypical Finding and the information described in DC 7.1.3 (b)-(f).
(b) If FINA receives a request, either from a Major Event Organization shortly before one of its International Competitions or a request from a sport organization responsible for meeting an imminent deadline for selecting team members for an International Competition, to disclose whether any Athlete identified on a list provided by the Major Event Organization or sport organization has a pending Atypical Finding, FINA shall so advise the Major Event Organisation or sports organisation after first providing notice of the Atypical Finding to the Athlete.

[Comment to DC 7.2.4(b): Under the circumstance described in DC 7.2.4(b), the option to take action would be left to the Major Event Organization or sport organization consistent with its rules.]